Case study
On May 9th, 2023, a U.S. Border Patrol detained a family of five near Brownsville, TX. During processing, one of the family members, an eight-year-old girl, ADRA, was noted to have sickle cell anemia and a heart disease condition. Five days after they arrived at the Donna Facility, on May 14th, ADRA displayed symptoms, including abdominal pain and fever, and tested positive for Influenza A. She was administered medication and transferred to a designated isolation unit at the Harlingen Border Patrol Station. Despite her deteriorating condition and her mother’s urgent requests for medical intervention, there were no documented consultations with an on-call physician or considerations for her transfer to a local hospital. On May 17th, ADRA’s health critically declined, marked by multiple visits to the medical unit for vomiting and abdominal pain. An ambulance was dispatched only after ADRA experienced a seizure and became unresponsive, Fig. 1. Her subsequent death was deemed a “preventable tragedy” attributed to systemic failures in the Border Patrol’s medical care and decision-making processes in a juvenile care monitor’s report.1
Impact
This article adds to the existing literature by:
-
Summarizing the gap in age-specific guidelines for six chronic diseases that occur in children and adolescents held in custody.
-
Identifying the lack of adequate intervention strategies for acute management of chronic diseases for youth held in custody and strategies for improving health equity.
Introduction
The American Pediatric Society’s President Issue of the Year is: Improving quality health care for incarcerated youth and adolescents.2 As part of this year-long initiative, our goal in this commentary is to describe the absence of medical guidelines for children and adolescents with chronic diseases held in jails, prisons, juvenile facilities, and immigration detention facilities (referred to subsequently as custodial settings). Evidenced-based guidelines acknowledging that our children’s chronic diseases exist in custodial settings is the first step in ensuring health equity for this near invisible, vulnerable, and prominent population of children and adolescents in the United States.
The health care for youth and adolescents held in custody remains challenging for health care providers. Annually, about 128,000 young individuals are admitted on delinquency charges.3 Compounding this issue, the number of unaccompanied minors at the U.S. southern border has reached unprecedented numbers, with over 131,519 unaccompanied children in the October 2022 to September 2023 fiscal year alone.4 The number of detained youths, coupled with the lack of clear and robust guidelines for clinical care management for children held in custody, presents a less-than-optimal healthcare environment.
The National Commission on Correctional Health Care (NCCHC) has established minimum health care standards for children and children in custodial settings.5 The NCCHC standards provide administrative and procedural guidance for delivering health care, for example, specifying the role and responsibilities of clinicians versus custodial staff and minimum required procedures for documentation, among many other recommendations. The NCCHC accreditation is not mandatory or published, and many states choose not to accredit services under NCCHC standards. The NCCHC’s mandate does not include developing evidence-based clinical guidelines for children and adolescents in custody but instead emphasizes the need for “clinical protocols [that] are consistent with national clinical practice guidelines”.5 Hence, the national clinical practice guidelines from the corresponding subspeciality-associated professional organizations are the standard for health care for youth held in custody. However, the age-specific subspecialty evidence guidelines for children held in custody are not commonly available.
The absence of age-specific guidelines for common life-threatening chronic diseases is a gap in improving child and adolescent health care. To address this gap, we identified six chronic diseases in children and adolescents associated with frequent exacerbations requiring prompt intervention to prevent lifelong sequelae: asthma, cystic fibrosis, type 1 diabetes, epilepsy, cancer, and sickle cell disease. We selected chronic diseases based on the observation that if a child or adolescent arrived in the Emergency Department with an acute exacerbation of their established chronic disease, the patient would have an emergency severity index of at least 2, a triage scale in a pediatric emergency department, indicating nursing triage within 20 minutes.6
Existing clinical practice guidelines and role of sub-specialists
Among the selected six chronic diseases, only three specific evidence-based clinical guidelines addressed acute medical management of adults held in custody.7,8,9 No professional organization had pediatric-specific evidence-based clinical guidelines tailored to the needs of youth in custody, Table 1.7,8,9,10,11,12 This lack of age-specific guidelines for chronic disease care for youth highlights the need for further attention to the unique circumstances of the health needs of children and adolescents in custodial settings.
Youth in custody face numerous challenges in accessing healthcare services, such as limited resources, fragmented healthcare systems, and insufficient coordination between prison healthcare teams and external healthcare providers. Moreover, custodial facilities may lack the necessary infrastructure and specialized healthcare personnel to manage the time-sensitive acute medical needs of youth with chronic diseases. Despite the limitations of custodial facilities in healthcare delivery, the United States Supreme Court has held that “deliberate indifference” to the “serious medical needs” of incarcerated people violates the Constitution.13 We recognize the spirit of the court decision: individuals held in custody should receive the same level of care as if they were not in custody. However, the absence of clinical care guidelines that address the unique custodial setting has three immediate consequences. First, no actionable strategy is established to ensure youth with chronic disease exacerbation receive time-sensitive health care. Second, healthcare providers in these custodial facilities do not benefit from the evidence-based standards required for ongoing quality improvement strategies. Third, there is no accountability when the health care provider or system fails to deliver standard care in the custody setting. Unfortunately, the current absence of evidence-based guidelines can lead to a below-the-standard care approach for acutely ill youth experiencing a time-sensitive exacerbation of their chronic disease.
A unique challenge in implementing clinical standards for youth in custody is the absence of best practices for communicating between the healthcare staff in custody, the healthcare providers outside the community medical facility or practice (general pediatric providers and sub-specialty providers), and the youth and their parents. Given the wide range of healthcare needs of the incarcerated youth population, a clear and actionable communication strategy and a healthcare plan are required to ensure health equity for children with chronic disease; pediatric sub-specialists and pediatricians with expertise in carceral healthcare should be engaged in developing and implementing evidence-based guidelines and institution-specific protocols for care coordination. Strategies that include telemedicine, shared electronic health records, and multi-disciplinary care teams that involve specialty care providers inside facilities and in the community can facilitate seamless and timely communication between the two healthcare facilities. An important step towards this goal is ensuring pediatric sub-specialists understand the unique aspects of the custodial settings concerning their patient’s health and healthcare and acknowledge their role in championing the health of young people in custody. To our knowledge, few pediatric subspecialty training programs include learning objectives on managing acute exacerbations of the chronic care of children or adolescents held in custody.
We identified six chronic diseases requiring acute management while youth are held in custody. None of the professional society’s established developed age-specific evidence-based guidelines, Table 1. The list of chronic diseases that affect children and require timely management is far greater than the six chronic diseases that we identified, including the most common chronic condition in youth held in custody, mental illness. Given the prevalence and acute mental health care crisis in the United States, the subject matter is worthy of a stand-alone commentary. Furthermore, we did not include the importance of chronic illness treatment and ongoing modifiable healthcare plans for entry and exit from the carceral facility back into the community.
Action agenda for sub-specialty professional societies
The care of children and adolescents with acute exacerbations of these six life-threatening chronic conditions (Type 1 diabetes, cystic fibrosis, sickle cell disease, epilepsy, cancer, and asthma) requires evidence-based guidelines and standards in custodial settings to prevent mortality and morbidity. We recommend all evidence-based guidelines include the management of children and adolescents held in custody and the inclusion of the stakeholders (former adolescents held in custody, their healthcare providers, and their parents) to ensure participation in developing these guidelines. Table 2 includes actionable priorities for medical sub-specialty professional societies. Implementation science indicates that if evidence-based guidelines are used, our children and adolescents with chronic diseases held in custody will have a demonstrable decrease in morbidity and mortality. We can and should do better to improve health equity in this invisible but prominent and vulnerable population of children and adolescents held in custody.
Data availability
Data sharing does not apply to this article as no datasets were generated or analyzed during the current study.
References
Wise P. H. Juvenile Care Monitor Report. United States District Court for the Central District of California. Case No. CV 85-4544-DMG (AGRx). July 2023. https://youthlaw.org/cases/flores-v-reno.
Barnet E., DeBaun M. R. Increasing access to quality health care for incarcerated children American Pediatric Society issue of the year (2023-2024). Pediatric Research. (2023).
Rovner, J. Youth Justice by the Numbers; 2023. https://www.sentencingproject.org/policy-brief/youth-justice-by-the-numbers/#combined-detention-and-commitment-rates-by-state.
Wise, P. H. Advocacy for unaccompanied Migrant children in US detention. Pediatr. Clin. North Am. 70, 103–116 (2023).
Patients With Special Needs: National Commission on Correctional Health Care. 2023. [cited 2023 Oct 22]; Available from: https://www.ncchc.org/standards/.
Gilboy N., Tanabe P., Travers D. A., Rosenau A. M., Eitel D. R. Emergency Severity Index, Version 4: Implementation Handbook. AHRQ Publication No. 05-0046-2. Rockville, MD: Agency for Healthcare Research and Quality. May 2005. https://www.sgnor.ch/fileadmin/user_upload/Dokumente/Downloads/Esi_Handbook.pdf.
Lorber D. L. et al. Position Statement: Diabetes Management in Detention Facilities: American Diabetes Association; October 2021. https://www2.diabetes.org/sites/default/files/2021-11/ADA-position-statement-diabetes-management-detention-settings-2021.pdf.
Glauser, T. et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the american epilepsy society. Epilepsy Curr. 16, 48–61 (2016).
Asthma Action Plan: Asthma and Allergy Foundation of America; 2015. https://aafa.org/asthma/asthma-treatment/asthma-treatment-action-plan/.
Keyt H., Yankaskas J. R. Adult Care Clinical Care Guidelines: Cystic Fibrosis Foundation; 2004. https://www.cff.org/medical-professionals/adult-care-clinical-care-guidelines.
Rock, C. L. et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA: A Cancer J. Clin. 70, 245–271 (2020).
Brandow, A. M. et al. American Society of Hematology 2020 guidelines for sickle cell disease: acute and chronic pain management. Blood Adv. 4, 2656–2701 (2020).
Saloner, B., Eber, G. B., Sufrin, C. B., Beyrer, C. & Rubenstein, L. S. A human rights framework for advancing the standard of medical care for incarcerated people in the United States in the time of COVID-19. Health Hum. Rights 24, 59–75 (2022).
Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. www.covidence.org.
Acknowledgements
We thank the American Pediatric Society’s Advocacy and Policy Committee co-chairs, Jonathan Klein, MD, Lisa Chamberlain, MD, MPH, and Paul Wise, MD, American Pediatric Society member for valuable feedback on our article during the revision process. We thank Kristin Wuichet, PhD, for technical assistance with data visualization. We also thank Rachel Walden, MLIS, for her assistance with the medical literature search. No financial assistance was received in support of this article.
Author information
Authors and Affiliations
Contributions
Each author listed has met the Pediatric Research authorship requirements. Specifically, all authors contributed substantially to the conception and design, acquisition of data, or analysis and interpretation of data. All authors completed drafting or revising the article critically for important intellectual content. MRD completed the final approval of the version to be published.
Corresponding author
Ethics declarations
Competing interests
M.R. DeBaun and his institution sponsored two externally funded research investigator-initiated projects. Global Blood Therapeutics (GBT) provided funding for the cost of the clinical studies. GBT was not a co-sponsor of either study. Dr. DeBaun did not receive any compensation for the conduct of these two investigator-initiated observational studies. Dr. DeBaun was a medical advisor in developing the CTX001 Early Economic Model. Dr. DeBaun provided medical input on the economic model as part of an expert reference group for the Vertex/CRISPR CTX001 Early Economic Model in 2020. Dr. DeBaun consulted for the Forma Pharmaceutical company about sickle cell disease in 2021 and 2022. Dr. DeBaun is on the steering committee for a Novartis-sponsored phase II trial to prevent priapism in men with sickle cell disease. All other authors declare no potential conflict of interest.
Consent statement
Patient consent was not required for this review article.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Dickens, C., Ramesh, A., Adanlawo, T. et al. Time-sensitive healthcare guidelines for youth with chronic diseases in custody: gaps in care. Pediatr Res (2023). https://doi.org/10.1038/s41390-023-02947-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41390-023-02947-x